Institut Paoli-Calmettes
In research, Institut Paoli-Calmettes stands highest in Medicine (#4,394 of 10,443 worldwide) and Health Sciences (#5,912 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 15.6× its share of world research.
- World rank, 2022–2025
- #10,405 of 28,054 · #7,272 all time
- Rank in France
- #381 of 1,422
- Research works
- 2.3k ▲ 3% vs 2013–17
- Citations
- 52k 22.3 per fractional work
- Top-10% rate
- 11.7% record average 16.5%
- Open access
- 27% world 28%
What is Institut Paoli-Calmettes known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,394 of 10,443 | 12.0% | 216 | #2883 | |
| Health SciencesDomain | #5,912 of 11,982 | 11.7% | 224 | #3750 |
Each strip is that field’s whole ranked pool, with the notch where Institut Paoli-Calmettes sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Institut Paoli-Calmettes specialise in?
Where its research is concentrated relative to its size: Oncology takes 15.6× the share of its output that it takes of world research.
- OncologySubfield · 50.1 works16×
- Pulmonary and Respiratory MedicineSubfield · 37.9 works8.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.
- Medicine 3.9×
- Immunology and Microbiology 2.5×
- Biochemistry, Genetics and Molecular Biology 2.0×
- Health Professions 1.0×
- Psychology 0.6×
- Physics and Astronomy 0.6×
- Economics, Econometrics and Finance 0.4×
- Dentistry 0.3×
- Veterinary 0.2×
- Social Sciences 0.2×
- Chemistry 0.2×
- Mathematics 0.1×
- Pharmacology, Toxicology and Pharmaceutics 0.1×
- Arts and Humanities 0.1×
- Neuroscience 0.1×
- Environmental Science 0.1×
- Nursing 0.1×
- Decision Sciences 0.1×
- Computer Science 0.0×
- Earth and Planetary Sciences 0.0×
- Engineering 0.0×
- Agricultural and Biological Sciences 0.0×
- Energy 0.0×
- Materials Science 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Institut Paoli-Calmettes?
Ranked on the composite score, Bernard Lelong, Luc Xerri and Thomas Prébet lead among researchers whose main affiliation is Institut Paoli-Calmettes.
- 1 Bernard Lelong France · #96,624 worldwide 148 citations · 54 works
- 2 Luc Xerri France · #108,814 worldwide 157 citations · 42 works
- 3 Thomas Prébet France · #113,741 worldwide 167 citations · 41 works
- 4 Djamel Mokart France · #115,406 worldwide 162 citations · 28 works
- 5 Réda Bouabdallah France · #168,007 worldwide 131 citations · 24 works
- 6 Jean‐Robert Delpéro France · #169,635 worldwide 145 citations · 83 works
- 7 Christian Chabannon France · #171,017 worldwide 217 citations · 74 works
- 8 Marc Giovannini France · #199,383 worldwide 114 citations · 45 works
- 9 Réda Bouabdallah France · #201,034 worldwide 93 citations · 30 works
- 10 Anthony Gonçalvès France · #212,722 worldwide 214 citations · 86 works
Which keywords describe research at Institut Paoli-Calmettes?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Neoadjuvant Therapy, Prognostic Factors, Clinical Practice Guidelines, Tumor Microenvironment, Survival Analysis and Genetic Mutations.
- Tumor Regression
- Screening
- Genomic Profiling
- Molecular Subtypes
- Cholangiocarcinoma
- AML
- Preoperative Chemoradiotherapy
- Metastasis
- Prostate Cancer
- Clinical Guidelines
- Breast Cancer
- Quality of Life
- Gemcitabine
- Pancreatic Cancer
- Treatment
- Clinical Trials
- Survival Analysis
- Epidemiology
- Prognostic Factors
- Immunotherapy
- Chemotherapy
- Neoadjuvant Therapy
- Clinical Practice Guidelines
- Tumor Microenvironment
- Genetic Mutations
- Molecular Characterization
- Biomarkers
- Targeted Therapy
- Surgical Complications
- Hematopoietic Stem Cells
- Radiation Therapy
- Guidelines
- Radiotherapy
- Lymphoma
- Tumor Markers
- Acute Myeloid Leukemia
- Cancer Immunotherapy
- Robotic Surgery
- Metastatic
- Metastatic Breast Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy40▲ 20×22 topics
- Immunotherapy36▲ 18×18 topics
- Neoadjuvant Therapy28▲ 42×5 topics
- Prognostic Factors24▲ 19×14 topics
- Clinical Practice Guidelines21▲ 13×12 topics
- Epidemiology19▲ 1.68×57 topics
- Tumor Microenvironment19▲ 15×8 topics
- Survival Analysis16▲ 21×7 topics
- Genetic Mutations15▲ 12×13 topics
- Clinical Trials14▲ 7.5×13 topics
- Molecular Characterization14▲ 28×5 topics
- Treatment12▲ 3.5×23 topics
- Biomarkers12▲ 6.0×12 topics
- Pancreatic Cancer11▲ 36×3 topics
- Targeted Therapy11▲ 18×5 topics
- Gemcitabine11▲ 53×1 topic
- Surgical Complications11▲ 47×1 topic
- Quality of Life11▲ 2.6×16 topics
- Hematopoietic Stem Cells10▲ 42×3 topics
- Breast Cancer10▲ 15×10 topics
- Radiation Therapy10▲ 27×5 topics
- Clinical Guidelines9▲ 11×5 topics
- Guidelines9▲ 7.0×8 topics
- Prostate Cancer9▲ 24×5 topics
- Radiotherapy8▲ 7.7×12 topics
- Metastasis8▲ 8.1×12 topics
- Lymphoma8▲ 17×4 topics
- Preoperative Chemoradiotherapy7▲ 32×2 topics
- Tumor Markers7▲ 30×2 topics
- AML7▲ 49×1 topic
- Acute Myeloid Leukemia7▲ 49×1 topic
- Cholangiocarcinoma7▲ 31×2 topics
- Cancer Immunotherapy7▲ 16×3 topics
- Molecular Subtypes7▲ 28×3 topics
- Robotic Surgery7▲ 16×5 topics
- Genomic Profiling6▲ 22×2 topics
- Metastatic6▲ 37×2 topics
- Screening6▲ 24×2 topics
- Metastatic Breast Cancer6▲ 39×2 topics
- Tumor Regression6▲ 19×2 topics
Which research topics does Institut Paoli-Calmettes publish most on?
By volume in 2022–2025: Pancreatic and Hepatic Oncology Research, Acute Myeloid Leukemia Research, Cancer Immunotherapy and Biomarkers and Bladder and Urothelial Cancer Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pancreatic and Hepatic Oncology Research Oncology 11 works
- 2 Acute Myeloid Leukemia Research Hematology 7 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 6 works
- 4 Bladder and Urothelial Cancer Treatments Surgery 6 works
- 5 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 5 works
- 6 CAR-T cell therapy research Oncology 5 works
- 7 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 5 works
- 8 Psychoanalysis and Psychopathology Research Clinical Psychology 5 works
- 9 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 5 works
- 10 Colorectal Cancer Surgical Treatments Oncology 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institut Paoli-Calmettes's research output changed?
Output in 2018–2022 was 3% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Marseille
- Aix-Marseille Université
- Institut de Recherche pour le Développement
- Hôpital de la Timone
- Hôpital Nord
- Institut de Neurobiologie de la Méditerranée
- Hôpital Sainte-Marguerite
- Hôpital Européen
- Hôpital de la Conception
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.